Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Nymox Pharmaceutical Corporation (NASDAQ:NYMX) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of Nymox Pharmaceutical Corporation (NASDAQ:NYMX) concerning whether a series of statements by Nymox Pharmaceutical Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On August 10, 2016, an article was published in Seeking Alpha reporting that Nymox Pharmaceutical's management misled shareholders about its prospects while aggressively dumping stock without making timely disclosures to the SEC. 

On this news, NASDAQ:NYMX dropped as much as $1.47 per share, or 47.27%, to $1.64 during intraday trading on August 10, 2016.

Based in Nassau, The Bahamas, and founded in 1989 Nymox Pharmaceutical Corporation engages in the research and development of drugs for the aging population.

If you purchased shares of Nymox Pharmaceutical Corporation (NASDAQ:NYMX) on or before August 10, 2016, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185